Japanese Pharmacology & Therapeutics(JPT)
Vol. 26 No. 5 1998
* With abstract in English **In English
【GERD Society】
A comparison of clinical profiles of Muneyake symptoms between Japanese patients with reflux esophagitis and healthy Japanese subjects
A. Okada
Jpn Pharmacol Ther 1998 26(5) 661-4
Epidemiology of GERD
K. Kato
Jpn Pharmacol Ther 1998 26(5) 665-7
Effect of body position on lower esophageal sphincter(LES)pressure
K. Iwakiri, et al.
Jpn Pharmacol Ther 1998 26(5) 673-8
Evaluation of GERD in bronchial asthmatic patients
H. Nakase
Jpn Pharmacol Ther 1998 26(5) 679-82
Clinical diagnosis of Barrett's epithelium in Japanese patients
M. Nakamura, et al.
Jpn Pharmacol Ther 1998 26(5) 687-8
Clinical study of reflux esophagitis resistant to H2-receptor antagonists
S. Kurosawa
Jpn Pharmacol Ther 1998 26(5) 689-95
An index to predict outcome of surgery for reflux esophagitis based on the AFP classification
N. Omura
Jpn Pharmacol Ther 1998 26(5) 701-7
The pathophysiology and carrent treatment strategy for GERD, How far they are good?
K. Takano
Jpn Pharmacol Ther 1998 26(5) 711-7
Gastritis and reflux esophagitis after distal gastrectomy with Billroth-I reconstruction
M. Miyaji
Jpn Pharmacol Ther 1998 26(5) 719-23
Helicobacter pylori and GERD
John Lambert
Jpn Pharmacol Ther 1998 26(5) 729-38*
Maximum tolerated dose and repeated dose toxicity studies of triethylenetetramine dihydrochloride a copper chelating agent by oral administration to beagle dogs
S. Maemura, et al.
Jpn Pharmacol Ther 1998 26(5) 745-67**
The proliferation of the spinal neural cells of a normal mouse fetus under the influences of th propentofylline
K. Takahashi, et al.
Jpn Pharmacol Ther 1998 26(5) 769-72*
Investigation on the absorption site of 14C-talipexole in rats
R. Imanishi, et al.
Jpn Pharmacol Ther 1998 26(5) 773-4
Characterization of the vasodilating effects of NKH477 a novel forskolin derivative in isolated rat aortae canine arteries and rabbit femoral arteries and veins
M. Himeta
Jpn Pharmacol Ther 1998 26(5) 775-85*
Experimental model of indometacin-induced gastric mucosal lesions in lewis rats and the response of several anti-ulcer drugs in the model
Y. Katoh
Jpn Pharmacol Ther 1998 26(5) 787-95*
Metabolic fate of TAT-59(3rd Report)
-Absorption and metabolism of TAT-59-
K. Ikeda
Jpn Pharmacol Ther 1998 26(5) 797-807*
Metabolic fate of TAT-59(4th Report)
-Species difference dose response and protein binding-
H. Masuda
Jpn Pharmacol Ther 1998 26(5) 809-28*
Study of percutaneous administration of indomethacin-contained cream (Patecs cream) on muscle and plasma indomethacin level in rats
N. Yamazaki
Jpn Pharmacol Ther 1998 26(5) 829-33
Studies on safety of CT-II an extract from nomame herba in rats
-Results of 3 months’treatment-
M. Egawa
Jpn Pharmacol Ther 1998 26(5) 835-8
Studies on safety of CT-II an extract from nomame herba in human
-Results of consecutive administration for 7 Days-
S. Sumino
Jpn Pharmacol Ther 1998 26(5) 839-43
A dose finding test of ulinastatin(MR-20)for ulcerative colitis
R. Narisawa
Jpn Pharmacol Ther 1998 26(5) 845-55
Effect of sarpogrelate hydrochlthoride for arteriosclerosis obliterans with diabetic patients
S. Uehara
Jpn Pharmacol Ther 1998 26(5) 857-62
Physiological assessment of loxoprofen sodium used in treatment of low back pain
K. Satake
Jpn Pharmacol Ther 1998 26(5) 863-70
Clinical efficacy of lansoprazole in treatment of gastric ulcer induced by NSAIDs
A. Maeda
Jpn Pharmacol Ther 1998 26(5) 871-6